A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas

NCT01130077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Pediatric Pontine Glioma
Newly Diagnosed Pediatric High Grade Glioma
Recurrent Pediatric High Grade Glioma
Recurrent Pediatric Low Grade Glioma

Interventions

BIOLOGICAL: HLA-A2 restricted glioma antigen peptides vaccine
BIOLOGICAL: Poly-ICLC

Sponsor

James Felker

Collaborators

[object Object]
[object Object]
[object Object]